e-learning
resources
Virtual 2021
06.09.2021
Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Familial Pulmonary Fibrosis: experience from a tertiary hospital
J. Pinto (Porto, Portugal), P. Mota (Porto, Portugal), N. Melo (Porto, Portugal), A. Morais (Porto, Portugal), H. Novais E Bastos (Porto, Portugal)
Source:
Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Session:
Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Session type:
E-poster
Number:
2370
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Pinto (Porto, Portugal), P. Mota (Porto, Portugal), N. Melo (Porto, Portugal), A. Morais (Porto, Portugal), H. Novais E Bastos (Porto, Portugal). Familial Pulmonary Fibrosis: experience from a tertiary hospital. 2370
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Cardiac sarcoidosis: a tertiary centre experience
Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype
Year: 2018
Primary Pulmonary Amyloidosis - The experience at a tertiary hospital on the Gold Coast, Australia
Source: International Congress 2018 – CC6 Interstitial lung diseases
Year: 2018
Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis?
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Pulmonary aspergillous; clinical features and outcomes in a tertiary care hospital
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Diffuse pulmonary ossification in Idiopathic Pulmonary Fibrosis: Forli 10-year experience
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017
Clinical experience with nintedanib for IPF in 3 UK tertiary referral centres
Source: International Congress 2016 – IPF treatment II
Year: 2016
Pulmonary embolism in children in a tertiary hospital in Bogota Colombia
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015
Non-Cystic Fibrosis Bronchiectasis in children: a single center experience.
Source: International Congress 2019 – A mixture of rare lung diseases
Year: 2019
Clinical findings at initial presentation of IPF patients at a university hospital referral center
Source: International Congress 2014 – ILDs 5
Year: 2014
Idiopathic Pulmonary Fibrosis: mortality trends in Chile
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019
Types of interstitial lung diseases and comparison on survival of idiopathic and secondary types in a tertiary care setting of Sri Lanka
Source: International Congress 2014 – ILDs 6
Year: 2014
Pulmonary nocardiosis in renal transplant patients in a tertiary care hospital in Pakistan
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020
Follow-up of Congenital Lung Malformations (CLM) in a Pediatric tertiary center
Source: International Congress 2018 – Orphan diseases in children
Year: 2018
Role of Biomarkers for Predicting suspecting Malignant Mesothelioma in patients with Pleural Effusion presenting to a tertiary care hospital
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019
Clinical characteristics of patients with Idiopathic pulmonary fibrosis in a tertiary care center of a developing country
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Idiopathic pulmonary fibrosis and systemic sclerosis-interstitial lung disease: features at admission to a tertiary pulmonology unit.
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Pulmonary Alveolar Microlithiasis: From Diagnosis to Transplant: An Indian Experience
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019
Cystic fibrosis centre care – paediatrics
Source: School Course 2013 - Cystic Fibrosis
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept